Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA

Thrombosis Research

Volumn 104, Issue 3, 2001, Pages 181-186

  Prisco, Domenico ^a,b   Fedi, Sandra ^a   Antonucci, Emilia ^a   Capanni, Monia ^a   Chiarugi, Ludia ^a   Chioccioli, Marco ^a   Falai, Massimiliano ^a   Giglioli, Cristina ^a   Abbate, Rosanna ^a   Gensini, Gian Franco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Sez Clin Med Gen Clin Spec   (Italy)

Author keywords

Clinical restenosis; PAI 1 activity; PTCA; Stent

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; D DIMER; FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; AGED; ARTICLE; BALLOON DILATATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FIBRIN FORMATION; FOLLOW UP; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RESTENOSIS; RISK FACTOR; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIFIBRINOLYTIC AGENTS; BIOLOGICAL MARKERS; CORONARY RESTENOSIS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; RISK FACTORS; SERINE PROTEINASE INHIBITORS; STENTS;

EID: 0035500253     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00360-7     Document Type: Article

References (17)

1. Advances in coronary angioplasty
2. Improving of percutaneous coronary intervention
3. Impairment of early fibrinolytic activation after PTCA: A mechanism for restenosis-related clinical recurrence?
4. An increased thrombin generation is detectable for at least 1 week following elective percutaneous transluminal coronary angioplasty
5. Unstable angina: A classification
6. Transluminal treatment of atherosclerotic obstruction: Description of a new technique and a preliminary report of its application
7. Quantitative coronary angiography: Estimation of dimension hemodynamic resistance, atheroma mass of coronary artery lesions using arteriogram and digital computation
8. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
9. Exercise standards. A statement for healthcare professionals from the American Heart Association
10. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis
11. Impaired fibrinolysis early after PTCA is associated with restenosis
12. Predictive value of PAI-1 activity and Thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patient
13. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis
14. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen predict angiographic coronary restenosis
15. Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events
16. ACC/AHA Guide lines for coronary angiography: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on coronary angiography)
17. Correlation between coronary morphology and molecular markers of fibrinolysis in unstable angina pectoris